Dancann Pharma A/S filed its Annual on May 12, 2023 for the period ending Dec 31, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.056 DKK | -4.76% | +86.67% | +86.67% |
Mar. 29 | Dancann Pharma Plans Up to DKK19 Million Rights Issue | MT |
Feb. 28 | DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+86.67% | 1.34M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- DANCAN Stock
- News Dancann Pharma A/S
- Dancann Pharma A/S Auditor Raises 'Going Concern' Doubt